Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
– Sell
-1,862
Closed -$359K – 840
2021
Q1
$359K Buy
+1,862
New +$358K ﹤0.01% 686
2019
Q4
– Sell
-3,817
Closed -$580K – 678
2019
Q3
$580K Buy
+3,817
New +$603K 0.01% 540
2019
Q2
– Sell
-5,338
Closed -$857K – 683
2019
Q1
$857K Buy
+5,338
New +$828K 0.01% 711
2018
Q1
– Sell
-2,499
Closed -$372K – 990
2017
Q4
$372K Buy
+2,499
New +$340K ﹤0.01% 809
2016
Q3
– Sell
-3,473
Closed -$481K – 849
2016
Q2
$481K Sell
3,473
-183
-5% -$23.7K ﹤0.01% 747
2016
Q1
$461K Buy
+3,656
New +$465K ﹤0.01% 746
2015
Q2
– Sell
-5,660
Closed -$625K – 953
2015
Q1
$625K Buy
+5,660
New +$614K 0.01% 689

Other funds holding CLX

HBK Investments's CLX Position: Q2 2021 in Review

HBK Investments sold out of Clorox (CLX) in Q2 2021, closing a stake of 1,862 shares — an estimated $359K sold.

HBK Investments first reported a position in CLX in Q1 2015 and held it in 7 quarters. The position peaked at $857K in Q1 2019. 1,170 funds tracked by Wall St. Rank hold CLX as of Q2 2021.

  • HBK Investments reported no remaining Clorox position as of Q2 2021 after selling out during the quarter.
  • HBK Investments sold 1,862 Clorox shares in Q2 2021, an estimated $359K.
  • HBK Investments first reported a position in Clorox in Q1 2015 and held it in 7 quarters.
  • HBK Investments's Clorox position peaked at $857K in Q1 2019.
  • 1,170 funds tracked by Wall St. Rank held Clorox as of Q2 2021.

Based on HBK Investments's 13F filing for Q2 2021, filed 16 Aug 2021.